Aiding development of a new anti-cancer drug
Thursday, May 1, 2008 - 21:42
in Health & Medicine
CSIRO has entered into an agreement with Adelaide-based biotech company, Oncaidia Ltd, to make the company's new anti-cancer drug, Apomab(R), suitable for human trials. Oncaidia's Managing Director, Keith Smith, says Apomab has the potential to aid in the management of a number of human cancers that are currently difficult to treat - including prostate cancer and lung cancer...
Read the whole article on Science Centric
More from Science Centric
Related
- Broccoli compound targets key enzyme in late-stage cancerWed, 3 Dec 2008, 10:34:05 EST
- Human lung tumors destroy anti-cancer hormone vitamin D, Pitt researchers findMon, 20 Apr 2009, 16:23:10 EDT
- New study finds advanced liver cancer patients live longer by taking anti-cancer drug sorafenibThu, 24 Jul 2008, 20:36:45 EDT
- New drug shows promise in treating drug-resistant prostate cancerFri, 10 Apr 2009, 10:24:39 EDT
- Finding may explain anti-cancer activity of thiazole antibioticsTue, 11 Aug 2009, 20:21:53 EDT